Ozempic Ozempic is a GLP-1 agonist that contains the active ingredient semaglutide
Thalidomide a drug, perhaps known more for its controversial 1950s history as a sedative for pregnant women with morning sickness, which was withdrawn after it was found to lead to severe skeletal birth defects was repurposed and approved by the FDA about 60 years later for use in combination with dexamethasone in patients with newly diagnosed multiple myeloma
Perer J, Jandova J, Fimbres J, et al
Essentially the injection may be a temporary measure to fix levels
Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A et al (2018) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Take your weight in kilograms and divide it by your height in meters squared